BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4363816)

  • 1. Adverse interaction between steroid hormones and anticholinesterase drugs.
    Patten BM; Oliver KL; Engel WK
    Neurology; 1974 May; 24(5):442-9. PubMed ID: 4363816
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse interaction between corticosteroid hormones and anticholinesterase drugs.
    Patten BM; Oliver KL; Engel WK
    Trans Am Neurol Assoc; 1973; 98():248-52. PubMed ID: 4784943
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.
    Yamamoto K; Sawada Y; Iga T
    J Pharmacokinet Biopharm; 1996 Aug; 24(4):327-48. PubMed ID: 9044164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory action of dopamine on the rat anterior tibialis muscle preparation.
    Capetola R; Ferko AP; Calesnick B
    Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):107-13. PubMed ID: 4824885
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholinesterase inhibitors in myasthenia gravis.
    Lange MJ
    Practitioner; 1966 Mar; 196(173):448-53. PubMed ID: 5905423
    [No Abstract]   [Full Text] [Related]  

  • 6. Repetitive stimulation in myasthenia gravis: decrementing response revealed by anticholinesterase drugs.
    Scoppetta C; Casali C; D'Agostini S; La Cesa I; Parisi L
    Electroencephalogr Clin Neurophysiol; 1990 Feb; 75(2):122-4. PubMed ID: 1688768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essentials in the management of myasthenia gravis.
    Galdi AP
    Am Fam Physician; 1978 Jun; 17(6):95-102. PubMed ID: 655080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium.
    Valdrighi JB; Fleming NW; Smith BK; Baker GL; White DA
    Br J Anaesth; 1994 Feb; 72(2):237-9. PubMed ID: 8110583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contractile and phosphatidylinositol responses of rat trachea to anticholinesterase drugs.
    Shibata O; Tsuda A; Makita T; Iwanaga S; Hara T; Shibata S; Sumikawa K
    Can J Anaesth; 1998 Dec; 45(12):1190-5. PubMed ID: 10051938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of corticosteroids on the phrenic nerve-diaphragm of preparation treated with hemicholinium. A possible model of myasthenia gravis.
    Wolters MJ; Leeuwin RS
    Neurology; 1976 Jun; 26(6 PT 1):574-8. PubMed ID: 180452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.
    Foldes FF; Smith JC
    Ann N Y Acad Sci; 1966 Jan; 135(1):287-301. PubMed ID: 5221345
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of the anticholinesterase and anticurare effects of some cholinesterase inhibitors.
    Barrow ME; Johnson JK
    Br J Anaesth; 1966 Jun; 38(6):420-31. PubMed ID: 5944020
    [No Abstract]   [Full Text] [Related]  

  • 13. The neuromuscular pharmacology of germine-3-acetate and germine-3,16-diacetate.
    Standaert FG; Detwiler PB
    J Pharmacol Exp Ther; 1970 Feb; 171(2):223-41. PubMed ID: 5459059
    [No Abstract]   [Full Text] [Related]  

  • 14. Vecuronium block in the myasthenic patient. Influence of anticholinesterase therapy.
    Baraka A; Taha S; Yazbeck V; Rizkallah P
    Anaesthesia; 1993 Jul; 48(7):588-90. PubMed ID: 8102223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of cholinesterase inhibitors.
    Aquilonius SM; Hartvig P
    Clin Pharmacokinet; 1986; 11(3):236-49. PubMed ID: 3524957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis and management of myasthenia gravis.
    Walsh JC
    Med J Aust; 1974 Jun; 1(25):997-1001. PubMed ID: 4369281
    [No Abstract]   [Full Text] [Related]  

  • 17. Single fibre EMG in juvenile myasthenia gravis.
    Stalberg E; Hansson O
    Neuropadiatrie; 1973 Jan; 4(1):20-9. PubMed ID: 4349293
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium.
    Barber HE; Calvey TN; Muir KT
    Br J Pharmacol; 1979 Aug; 66(4):525-30. PubMed ID: 223706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the irreversible cholinesterase inhibitor, diisopropylfluorophosphate, on time course of end-plate currents in frog sartorius muscle.
    Kuba K; Albuquerque EX; Daly J; Barnard EA
    J Pharmacol Exp Ther; 1974 May; 189(2):499-512. PubMed ID: 4545375
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of corticosteroids on sciatic nerve-tibialis anterior muscle of rats treated with hemicholinium-3. An experimental approach to a possible mechanism of action of corticosteroids in myasthenia gravis.
    Leeuwin RS; Wolters EC
    Neurology; 1977 Feb; 27(2):171-7. PubMed ID: 189257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.